Q3 2024 Earnings Call Recap, Part 1

This is Part 1 of the paid subscriber exclusive long-form post for November.

(IMPORTANT NOTE: Even though I split this post into two parts, Substack is still saying it is still too long for email. If you are viewing this in your email browser I would recommend viewing it on the web or the Substack app. Part 1 alone is 7,951 words!)

Hello subscribers! Here is your first monthly long-form article. As a reminder you will receive one long-form post each month, and that one to two extra paid posts of medium length. And then short thoughts constantly in the Subscriber Chat. Exciting!  

For November I will give you thoughts, statistics, and analysis for 15 quarterly earnings calls I listened to and read the transcript twice.

The companies covered this quarter: KNSA, VRNA, APLS, ARQT, EOLS, TRVI, CMRX, PODD, DCTH, AVDL, SRRK, SWTX, SCPH, OCUL, CELC.

The first eight will be in Part 1, the second seven will be in Part 2.

I will continue to keep a company on the list each quarter as long as it’s interesting and possibly worthy of a long position. I expect each quarter there will be a couple names that are replaced with new companies but for the most part I will try to keep some consistency.

There will be a template at the start of each company section:

NASDAQ Stock Symbol: 

Company Name: 

Earnings Call Date, Call Time: 

Share Price Heading Into Call: 

Shares Outstanding: 

Market Capitalization: 

Share Price One Full Trading Session After Call: 

Stock Price Change: 

Market Capitalization One Full Trading Session After Call: 

…this will be followed by four sections of analysis…

Bottom Line Up Front:

Analyst Question Topics:

Pulled Quotes From Executives:

Additional Analysis:

The order of companies was determined by chronological order and if the calls happened at the same time then alphabetical order. In the end, it’s up to you to determine the worthiness of an investment or what weighting you should give it, if any. These are my opinions. I believe I have a very good track record but past performance is not indicative of future results.

Standard boilerplate disclaimer: I am not a financial advisor. This is not financial advice. This is not a solicitation to buy or sell securities. For research purposes only.

Alright, let’s get into it!